$60.5 Million is the total value of CVI Holdings, LLC's 47 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 100.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| RSLS | Exit | RESHAPE LIFESCIENCES INC | $0 | – | -16,574 | -100.0% | -0.05% | – |
| CLRBZ | Exit | CELLECTAR BIOSCIENCES INC*w exp 04/08/202 | $0 | – | -207,500 | -100.0% | -0.05% | – |
| IMNPQ | Exit | IMMUNE PHARMACEUTICALS INC | $0 | – | -251,029 | -100.0% | -0.06% | – |
| QUIK | Exit | QUICKLOGIC CORP | $0 | – | -58,043 | -100.0% | -0.08% | – |
| GLMD | Exit | GALMED PHARMACEUTICALS LTD | $0 | – | -14,895 | -100.0% | -0.22% | – |
| TROV | Exit | TROVAGENE INC | $0 | – | -307,445 | -100.0% | -0.30% | – |
| FCSC | Exit | FIBROCELL SCIENCE INC | $0 | – | -117,099 | -100.0% | -0.40% | – |
| SCYX | Exit | SCYNEXIS INC | $0 | – | -236,531 | -100.0% | -0.48% | – |
| SMHI | Exit | SEACOR MARINE HLDGS INC | $0 | – | -17,809 | -100.0% | -0.51% | – |
| KIN | Exit | KINDRED BIOSCIENCES INC | $0 | – | -45,057 | -100.0% | -0.60% | – |
| LMNR | Exit | LIMONEIRA CO | $0 | – | -25,946 | -100.0% | -0.80% | – |
| CHFS | Exit | CHF SOLUTIONS INC | $0 | – | -347,895 | -100.0% | -0.80% | – |
| CVM | Exit | CEL SCI CORP | $0 | – | -801,006 | -100.0% | -0.92% | – |
| PFIE | Exit | PROFIRE ENERGY INC | $0 | – | -277,721 | -100.0% | -1.17% | – |
| RKDA | Exit | ARCADIA BIOSCIENCES INC | $0 | – | -119,333 | -100.0% | -1.22% | – |
| KURA | Exit | KURA ONCOLOGY INC | $0 | – | -76,200 | -100.0% | -1.73% | – |
| Exit | EGALET CORPnote 5.500% 4/0 | $0 | – | -4,500,000 | -100.0% | -1.96% | – | |
| HMNY | Exit | HELIOS & MATHESON ANALYTICS | $0 | – | -8,023,500 | -100.0% | -3.10% | – |
| TELL | Exit | TELLURIAN INC NEW | $0 | – | -454,294 | -100.0% | -4.70% | – |
| VERI | Exit | VERITONE INC | $0 | – | -261,422 | -100.0% | -5.47% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -3,315,597 | -100.0% | -5.53% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| SENSEONICS HLDGS INC | 20 | Q4 2022 | 5.2% |
| VERB TECHNOLOGY CO INC | 20 | Q1 2024 | 0.2% |
| CHECK CAP LTD | 20 | Q1 2023 | 0.2% |
| MEDIGUS LTD | 19 | Q2 2023 | 0.1% |
| VERIFYME INC | 17 | Q2 2024 | 0.0% |
| GEOVAX LABS INC | 16 | Q2 2024 | 0.0% |
| BREEZE HOLDINGS ACQUISITN CO | 14 | Q1 2024 | 0.1% |
| LEXARIA BIOSCIENCE CORP | 14 | Q2 2024 | 0.1% |
| AMPLITECH GROUP INC | 14 | Q2 2024 | 0.0% |
| VERSUS SYSTEMS INC | 14 | Q2 2024 | 0.0% |
View CVI Holdings, LLC's complete holdings history.
Latest filings
| Type | Filed |
|---|---|
| N-PX | 2024-08-30 |
| 13F-HR | 2024-08-15 |
| 13F-HR | 2024-05-07 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-11 |
| 13F-HR | 2023-05-16 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
View CVI Holdings, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.